AVAIL Vapor Signs Groundbreaking U.S. FDA PMTA Deals
Dated Dec 11, 2019
AVAIL Vapor, LLC, a leading premium e-liquid manufacturing, regulatory and scientific services and retail business, today announces it has signed nine major brand FDA regulatory contracts. As a result, AVAIL will take the lead in submitting an array of products for the FDA’s premarket tobacco product application (PMTA) process – with the first of those applications being submitted in early in 2020, – and completing the portfolio before the May 2020 deadline.
Dated Dec 11, 2019